Venus Concept Announces First Patient Treatment in Study Evaluating the Safety and Efficacy of Aime™ Next Generation Robotic Technology for the Treatment of Moderate to Severe Facial Wrinkles
Retrieved on:
Monday, April 25, 2022
Dr. Dayan continued: We are pleased to have successfully completed the initial patient treatment with the Aime robotic platform for this important clinical study.
Key Points:
- Dr. Dayan continued: We are pleased to have successfully completed the initial patient treatment with the Aime robotic platform for this important clinical study.
- Aime could very well differentiate adopting clinicians as the use of robotic technology emerges in aesthetic procedures.
- The study is a prospective, multicenter clinical study evaluating the safety and efficacy of mechanical coring to improve the appearance of wrinkles of the face.
- Venus Concepts product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve and Venus Viva MD.